Results 21 to 30 of about 3,448,511 (303)
State of the globe: Evaluating the existence of extended spectrum beta lactamases
Stephen E Mshana
doaj +3 more sources
Cefotaxime/sulbactam: clinical and pharmacological characteristics [PDF]
The recently approved cefotaxime/sulbactam, combination of third-generation cephalosporin (cefotaxime) and beta-lactamase inhibitor (sulbactam), can combat resistance mechanisms associated with the production of serine beta-lactamases, including some ...
Ortenberg E.A., Golub A.V.
doaj +1 more source
Purpose The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) has been increasing worldwide since the early 2000s. E. coli is found in 70–90% of community-acquired urinary tract infections (CA-UTIs).
S. Larramendy +6 more
semanticscholar +1 more source
Antibacterial Mechanism of Dihydrotanshinone I
The antimicrobial activity and the underlying action mechanisms of dihydrotanshinone I against Staphylococcus aureus , methicillin-resistant Staphylococcus aureus , extended-spectrum beta-lactamases Staphylococcus aureus were investigated with Kleihauer ...
Lin Zhao +5 more
doaj +1 more source
The problem of the formation and spread of resistance to β-lactam antibiotics in clinically significant types of microorganisms is extremely important, since β-lactams traditionally form the basis of the treatment of bacterial infections.
Olena Peretyatko +4 more
doaj +1 more source
Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment.
Antibiotic resistance is a problem of deep scientific concern both in hospital and community settings. Rapid detection in clinical laboratories is essential for the judicious recognition of antimicrobial resistant organisms.
Sibhghatulla Shaikh +4 more
semanticscholar +1 more source
The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases
The β-lactams—a large class of diverse compounds—due to their excellent safety profile and broad antimicrobial spectrum are considered to be the most widely used therapeutic class of antibacterials prescribed in human and veterinary clinical practices ...
S. ur Rahman +5 more
semanticscholar +1 more source
Background Extended spectrum Beta-lactamases (ESBLs) and AmpC beta-lactamases (AmpC) are the common enzymes produced by gram negative bacilli, which are their main mechanisms of resistance to all generations of cephalosporins.
Saba Gebremichael Tekele +4 more
semanticscholar +1 more source
Exposure assessment of extended-spectrum beta-lactamases/AmpC beta-lactamases-producing in meat in Denmark [PDF]
Extended-Spectrum Beta-Lactamases (ESBL) and AmpC Beta-Lactamases (AmpC) are of great concern because of their ability to cause antimicrobial resistance in Enterobacteriaceae hampering the effect of treatment with beta-lactam antibiotics.
da Costa, P. +3 more
core +1 more source
Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains [PDF]
Intestinal carriage of extended-spectrum beta-lactamase (ESBL) -producing bacteria in food-producing animals and contamination of retail meat may contribute to increased incidences of infections with ESBL-producing bacteria in humans.
Munckhof, M.P., Van den +33 more
core +1 more source

